Severe azathioprine-induced liver injury 22 months after initiation of treatment
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
---|---|
Enthalten in: |
Drug and therapeutics bulletin - 62(2024), 4 vom: 25. März, Seite 60-63 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cataletti, Giovanni [VerfasserIn] |
---|
Links: |
---|
Themen: |
Azathioprine |
---|
Anmerkungen: |
Date Completed 27.03.2024 Date Revised 27.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/dtb.2024.253505rep |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367916479 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367916479 | ||
003 | DE-627 | ||
005 | 20240327235731.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240202s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/dtb.2024.253505rep |2 doi | |
028 | 5 | 2 | |a pubmed24n1351.xml |
035 | |a (DE-627)NLM367916479 | ||
035 | |a (NLM)38302287 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cataletti, Giovanni |e verfasserin |4 aut | |
245 | 1 | 0 | |a Severe azathioprine-induced liver injury 22 months after initiation of treatment |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2024 | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Drugs and medicines | |
650 | 4 | |a Gastroenterology | |
650 | 4 | |a Liver disease | |
650 | 7 | |a Azathioprine |2 NLM | |
650 | 7 | |a MRK240IY2L |2 NLM | |
650 | 7 | |a Immunosuppressive Agents |2 NLM | |
700 | 1 | |a Santagata, Fabrizio |e verfasserin |4 aut | |
700 | 1 | |a Pastorelli, Luca |e verfasserin |4 aut | |
700 | 1 | |a Battezzati, Pier Maria |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug and therapeutics bulletin |d 1965 |g 62(2024), 4 vom: 25. März, Seite 60-63 |w (DE-627)NLM000016047 |x 1755-5248 |7 nnns |
773 | 1 | 8 | |g volume:62 |g year:2024 |g number:4 |g day:25 |g month:03 |g pages:60-63 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/dtb.2024.253505rep |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 62 |j 2024 |e 4 |b 25 |c 03 |h 60-63 |